Business Wire Feed
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced first patient enrollments in the multi-center first-in-human feasibility more...
Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo
Heru’s PretestPro™ Allows Full-Stack Pretesting in Just Under 2 MinutesMIAMI--(BUSINESS WIRE)--#AIPoweredVisionDiagnostics--Heru, the leader in AI-powered vision diagnostics, today announced it is showcasing the new PretestPro™ on its Heru wearable platform at booth #2138 during the more...
SS&C GlobeOp Hedge Fund Performance Index and Capital Movement Index
SS&C GlobeOp Hedge Fund Performance Index: February performance 0.59% SS&C GlobeOp Capital Movement Index: March net flows advance 0.87%WINDSOR, Conn.--(BUSINESS WIRE)--SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the gross return of the SS&C GlobeOp more...
Prodalim Strengthens its Functional Platform to Enter the Fast-Growing Nutraceutical Market with the Acquisition of Sylvestre, a Market Leader in Botanical Extracts Based in Brazil
The acquisition positions Prodalim to deepen its fast-growing functional beverage solutions offering, accelerate its expansion into the US functional ingredients market, and broaden its presence across emerging marketsWinter Garden, Florida--(BUSINESS WIRE)--Prodalim, a global leader in more...
Compass Pathways to Present at Stifel 2026 Virtual CNS Forum on March 18, 2026
LONDON & NEW YORK--(BUSINESS WIRE)--$CMPS #Biotech--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will attend the Stifel 2026 Virtual CNS more...
Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal®
FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced the publication of the PREDICT-DNA study in the Journal of Clinical Oncology. The article, "The Pathologic Response Evaluation and more...
Nature Medicine Study Shows AI Outperforms Therapists on Cognitive Behavioral Therapy
Randomized, double-blind trial shows Limbic’s clinical reasoning layer turns leading LLMs into mental health specialists, achieving gold-standard clinical performanceSAN FRANCISCO & LONDON--(BUSINESS WIRE)--Limbic, the leading evidence-based clinical mental health AI company, today announced the publication more...
WHOOP and Samuel Ross MBE Announce First Limited-Edition Collection Drop for PROJECT TERRAIN
The new WHOOP x SR_A collection includes bespoke, performance-driven WHOOP bands, apparel and outerwearBOSTON--(BUSINESS WIRE)--WHOOP, the human performance company, today announces that the first limited-edition collection drop of PROJECT TERRAIN, the multi-year collaboration between WHOOP more...
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets
International companies find a new, frictionless path to secure regional approvals in VeristatSOUTHBOROUGH, Mass.--(BUSINESS WIRE)--#Biotech--Veristat, a global clinical research organization (CRO) and consultancy specializing in complex studies, announced expanded regulatory and clinical trial services to more...
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors
Latest milestone underscores accelerating regulatory momentum for the company’s lead investigational Helicon peptide, following FDA Fast Track Designation in desmoid tumorsCAMBRIDGE, Mass.--(BUSINESS WIRE)--Parabilis Medicines, a clinical-stage biopharmaceutical company committed to creating extraordinary medicines for people more...
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Highlights Agreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to evolve a portfolio of extrafine formulation Carbon Minimal Inhalers1, ensuring patients retain continuity of care while reducing carbon emissions Bespak’s more...
Aplantex and Investissement Québec Team up to Produce Molecules for the Cosmetic and Food Industries
MONTREAL--(BUSINESS WIRE)--Aplantex and Investissement Québec are pleased to announce a partnership to boost the deployment of Aplantex's innovative green biotechnology. Under this partnership, Investissement Québec provides Aplantex access to its technological demonstration plant for sustainable more...
Kurin Prevails in Federal Appellate Court in Long-Running Litigation with Magnolia Medical Technologies
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., a leader in innovative blood culture collection technology designed to reduce contamination and improve patient outcomes, announced today that the United States Court of Appeals for the Federal Circuit has ruled more...
Gene Therapy for Duchenne Muscular Dystrophy: Genethon Confirms Two-Year Efficacy in Patients Treated with Its Drug Candidate GNT0004 at Therapeutic Dose in the First Phase of Its Clinical Trial
EVRY, France--(BUSINESS WIRE)--Genethon, a pioneer and leader in gene therapy for rare diseases, unveiled results at the MDA Conference in Orlando confirming the long-term efficacy of its GNT0004 gene therapy in Duchenne muscular dystrophy in more...
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health
£65m investment in new oral health manufacturing plant in Shanghai to support growth in the world’s largest gum health market Haleon aiming to extend gum health brand parodontax to 30 Chinese cities by end of more...
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples
LYON, France--(BUSINESS WIRE)--Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass more...
Dexcom Showcases Breakthrough Outcomes for People With Type 2 Diabetes and Product Roadmap at ATTD 2026
New registry study data shows that long-term use of Dexcom G7 supports weight management and lowers A1C for people with Type 2 diabetes who aren’t on insulin therapy1, reinforcing the need to broaden CGM access more...
Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan
Japan is one of the world's most important pharmaceutical markets after the US and Europe. Neupharma’s team has extensive experience in developing and successfully commercialising orphan drugs as well as speciality care medicines in Japan, more...
New Report Shows Increase in Colorectal Screenings at Ambulatory Surgery Centers (ASCs) Versus Hospitals
Volume of endoscopic and laparoscopic colorectal procedures performed in an outpatient setting increased 50% – improving patient access and creating opportunities for device companiesBOSTON--(BUSINESS WIRE)--#MedTech--AcuityMD, the intelligence platform for MedTech, announced data revealing increased access more...
Peptilogics Begins Pivotal Trial of First-Ever Drug Designed to Cure Medical Device-Related Infections
First Patient Enrolled in RETAIN Phase 2/3 Registration Trial of PLG0206, a First-in-Class Anti-Biofilm Drug Initially Targeting Prosthetic Joint InfectionPITTSBURGH--(BUSINESS WIRE)--#DrugTrial--Peptilogics, a surgical therapeutics company dedicated to curing and preventing devastating medical device-related infections (MDRI), more...
The KCAS Bio – Lyon, France Site Renews Its GLP Compliance Statement, Strengthening Its Support for IND-Enabling Studies Through Bioanalysis and Biomarkers
KANSAS CITY, Kan.--(BUSINESS WIRE)--KCAS Bio today announced that its European site in Lyon, France, has successfully renewed its Statement of Compliance with Good Laboratory Practices (GLP) according to Directive 2004/9/CE (safety tests), confirming the site’s more...
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
Fully Closed-Loop System Feasibility Study to be presented at Insulet Symposium and in e-Poster during ATTD 2026 Real World Evidence of Settings Optimization in Omnipod 5 Users will also be shared Other activities include immersive more...
Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker Test, FoundationOne®Liquid CDx
Foundation Medicine remains one of the chief contributors to ComboMATCH, the largest of its kind initiative to test effectiveness of biomarker-targeted cancer treatment combinations BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, today more...
HeartBeam and Mount Sinai Announce Strategic AI Collaboration to Bring Clinical-Grade Heart Monitoring into the Home
Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk Combines Mount Sinai’s world-class AI and clinical expertise with HeartBeam’s groundbreaking 3D ECG signal collection more...
NationsBenefits and Food City Partner to Expand Flex Card Access for Rx and OTC Health Needs Across Southeastern Communities
PLANTATION, Fla.--(BUSINESS WIRE)--#NationsBenefits--NationsBenefits®, the leading healthcare benefits and fintech platform, today announced a new retail network integration with Food City, a trusted supermarket chain serving communities across Tennessee, Kentucky, Virginia, Georgia, and Alabama. Through this more...